A phase 3, randomized,bouble-blind,active comparator study of the efficacy and safety of bBow015, a biosimilar infliximab,in patients with active rheumatoid arthritis on stable methotrexate doses |
| |
| Affiliation: | 1. Division of Rheumatology, Center for Rheumatic Diseases, Pune, India;2. Department of Medicine, University of Massachusetts Medical School, Worcester, MA, United States;3. Epirus Biopharmaceuticals, Boston, MA, United States;4. ChanRe Rheumatology & Immunology Center & Research, India;5. St.John''s Medical College Hospital, Bengaluru, India;6. Department of Rheumatology, Fortis Hospital, Mumbai, India;7. Pentagon Multispeciality Clinic and Research Centre, Pune, India;8. Rathi Hospital, Ahmedabad, India;9. Kerala Institute of Medical Sciences, Kerala, India;10. Reliance Life Sciences, Mumbai, India;11. Epirus Biopharmaceuticals, Surrey, United Kingdom;12. Shneyer Statistics LLC,Denville, NJ, United States;1. Division of Gastroenterology, Lenox Hill Hospital, Northwell Health, 100 East 77th Street, New York, NY 10075, USA;2. Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, 1428 Madison Avenue, New York, NY 10029, USA;1. Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York;2. Gastrointestinal Unit, Centre for Molecular Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, Scotland;3. Department of Gastroenterology, University Hospital CHU of Liège, Liège, Belgium;1. Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark;2. Department of Surgery, Pelvic Floor Unit, Aarhus University Hospital, Aarhus, Denmark;3. Department of Radiology, Aarhus University Hospital, Aarhus, Denmark;4. Molecular Endocrinology and Stem Cell Research Unit, Department of Endocrinology and Metabolism, Odense University Hospital and Institute of Clinical Research, University of Southern Denmark, Denmark;1. St Vincent''s Hospital Melbourne, Department of Gastroenterology, Fitzroy, Australia;3. University of Melbourne, Medicine, Parkville, Australia;4. QIMR Berghofer Medical Research Institute, Gut Health Lab, Brisbane, Australia;5. Queensland X-ray, Medical Imaging, Brisbane, Australia;7. University of Queensland, Mater Research Institute, St Lucia, Australia;12. Liverpool Hospital, Medical Imaging, Liverpool, Australia;8. South Western Sydney Local Health District, Medicine, Liverpool, Australia;9. Alfred Health, Medical Imaging, Melbourne, Australia;71. Ingham Institute for Applied Medical Research, Medicine, Liverpool, Australia;123. University of New South Wales, South Western Sydney Clinical School, Sydney, Australia;84. Alfred Health, Gastroenterology, Melbourne, Australia;95. Royal Prince Alfred Hospital, Gastroenterology and Hepatology, Camperdown, Australia;77. Eastern Health, Radiology, Box Hill, Australia;1212. Imaging Associates Eastern Health, Medical Imaging, Melbourne, Australia;88. Peter MacCallum Cancer Centre, Cancer Imaging, Melbourne, Australia;99. Eastern Health, Gastroenterology, Box Hill, Australia;771. Fiona Stanley Hospital, Gastroenterology, Murdoch, Australia;12123. University of Western Australia, School of Medicine and Pharmacology, Crawley, Australia;884. Fiona Stanley Hospital, Medical Imaging, Murdoch, Australia;1. Department of Gastroenterology, Erasme Hospital, ULB, Brussels, Belgium;2. Laboratory of Experimental Gastroenterology, ULB, Brussels, Belgium |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
